IART

SEC source: 0001209191-17-020789 · doc4.xml · nonDerivative · entry 2

MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,825

SEC source: 0001209191-17-020784 · doc4.xml · nonDerivative · entry 3

GORELICK RICHARD D. · CIK 0001563554 · Corp VP, Gen Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,976

SEC source: 0001209191-17-020784 · doc4.xml · nonDerivative · entry 2

GORELICK RICHARD D. · CIK 0001563554 · Corp VP, Gen Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,139

SEC source: 0001209191-17-020780 · doc4.xml · nonDerivative · entry 3

DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,241

SEC source: 0001209191-17-020780 · doc4.xml · nonDerivative · entry 2

DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,569

SEC source: 0001209191-17-020782 · doc4.xml · nonDerivative · entry 3

Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,927

SEC source: 0001209191-17-020782 · doc4.xml · nonDerivative · entry 2

Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,022

SEC source: 0001209191-17-020779 · doc4.xml · nonDerivative · entry 3

Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,771

SEC source: 0001209191-17-020779 · doc4.xml · nonDerivative · entry 2

Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,250

SEC source: 0001209191-17-020775 · doc4.xml · derivative · entry 6

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 467,658

Underlying: Common Stock · 378 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/14/16 of which the first installment vested on 3/14/17 and which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation.

F3 · derivative.exercise_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/14/16 of which the first installment vested on 3/14/17 and which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation.

F3 · derivative.expiration_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/14/16 of which the first installment vested on 3/14/17 and which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation.

SEC source: 0001209191-17-020775 · doc4.xml · nonDerivative · entry 3

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,825

SEC source: 0001209191-17-020775 · doc4.xml · nonDerivative · entry 2

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,203

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-020775 · doc4.xml · nonDerivative · entry 1

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,825

SEC source: 0001209191-17-020777 · doc4.xml · nonDerivative · entry 3

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,925

SEC source: 0001209191-17-020777 · doc4.xml · nonDerivative · entry 2

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,055

SEC source: 0001209191-17-020792 · doc4.xml · derivative · entry 4

OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,213

Underlying: Common Stock · 2,213 shares

Expires 2025-03-13

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2017.

SEC source: 0001209191-17-020792 · doc4.xml · nonDerivative · entry 1

OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,443

SEC source: 0001209191-17-020802 · doc4.xml · derivative · entry 4

VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,655

Underlying: Common Stock · 2,655 shares

Expires 2025-03-13

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2017.

SEC source: 0001209191-17-020802 · doc4.xml · nonDerivative · entry 1

VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,273

SEC source: 0001209191-17-020796 · doc4.xml · derivative · entry 4

REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES-SPC SURGICAL SOLUTION

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,638

Underlying: Common Stock · 6,638 shares

Expires 2025-03-13

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2017.

SEC source: 0001209191-17-020796 · doc4.xml · nonDerivative · entry 1

REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES-SPC SURGICAL SOLUTION

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,335

SEC source: 0001209191-17-020789 · doc4.xml · derivative · entry 4

MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,363

Underlying: Common Stock · 3,363 shares

Expires 2025-03-13

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2017.

SEC source: 0001209191-17-020789 · doc4.xml · nonDerivative · entry 1

MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,218

SEC source: 0001209191-17-020784 · doc4.xml · derivative · entry 4

GORELICK RICHARD D. · CIK 0001563554 · Corp VP, Gen Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,576

Underlying: Common Stock · 5,576 shares

Expires 2025-03-13

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2017.

SEC source: 0001209191-17-020784 · doc4.xml · nonDerivative · entry 1

GORELICK RICHARD D. · CIK 0001563554 · Corp VP, Gen Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,749

SEC source: 0001209191-17-020780 · doc4.xml · derivative · entry 4

DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,062

Underlying: Common Stock · 11,062 shares

Expires 2025-03-13

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2017.

SEC source: 0001209191-17-020780 · doc4.xml · nonDerivative · entry 1

DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,799

SEC source: 0001209191-17-020782 · doc4.xml · derivative · entry 4

Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,337

Underlying: Common Stock · 4,337 shares

Expires 2025-03-13

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2017.

SEC source: 0001209191-17-020782 · doc4.xml · nonDerivative · entry 1

Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,378

SEC source: 0001209191-17-020779 · doc4.xml · derivative · entry 4

Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,354

Underlying: Common Stock · 20,354 shares

Expires 2025-03-13

F1 · derivative.exercise_date: 33% of the shares of stock options will vest each of the first and second anniversaries of the grant date of 3/13/2017 and 34% of the shares of stock options will vest on the third anniversary of the grant date of 3/13/2017.

SEC source: 0001209191-17-020779 · doc4.xml · nonDerivative · entry 1

Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,043

SEC source: 0001209191-17-020775 · doc4.xml · derivative · entry 5

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 468,036

Underlying: Common Stock · 21,750 shares

Expires not disclosed

F2 · derivative.exercise_price: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/2017 which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. This award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.

F2 · derivative.exercise_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/2017 which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. This award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.

F2 · derivative.expiration_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/2017 which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. This award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.

SEC source: 0001209191-17-020775 · doc4.xml · derivative · entry 4

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,071

Underlying: Common Stock · 84,071 shares

Expires 2025-03-13

F1 · derivative.exercise_date: The grant will vest as to one-third of the shares on the first anniversary of the grant date of 3/13/2017 and thereafter in monthly installments through the following twenty-four months.

SEC source: 0001209191-17-020777 · doc4.xml · derivative · entry 4

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,947

Underlying: Common Stock · 3,947 shares

Expires 2025-03-13

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2017.

SEC source: 0001209191-17-020777 · doc4.xml · nonDerivative · entry 1

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,540

SEC source: 0001209191-17-026713 · doc4.xml · nonDerivative · entry 2

Murphy Raymond G. · CIK 0001461806 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse as trustee of a revocable trust

Disclosed balance after: 28,761

F1 · kind: The reporting person transferred these shares to a revocable trust of which the reporting person's spouse is trustee. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

SEC source: 0001209191-17-026713 · doc4.xml · nonDerivative · entry 1

Murphy Raymond G. · CIK 0001461806 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,133

F1 · kind: The reporting person transferred these shares to a revocable trust of which the reporting person's spouse is trustee. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

SEC source: 0001209191-17-018270 · doc4.xml · derivative · entry 3

Murphy Raymond G. · CIK 0001461806 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,238 shares

Expires 2017-05-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the stock options vested every quarter from the grant date of 5/20/2009.

F4 · balance_after: This employee's stock option was previously reported as covering 7,829 shares of common stock at an exercise price of $21.48 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.

SEC source: 0001209191-17-018270 · doc4.xml · nonDerivative · entry 2

Murphy Raymond G. · CIK 0001461806 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,894

F2 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $42.84 to $43.09.

SEC source: 0001209191-17-018270 · doc4.xml · nonDerivative · entry 1

Murphy Raymond G. · CIK 0001461806 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,132

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4.

SEC source: 0001209191-17-015845 · doc4.xml · derivative · entry 4

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 311,588

Underlying: Common Stock · 40,000 shares

Expires 2020-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: One-third of the stock options vested on the first anniversary of the grant date which is March 1, 2012 and thereafter with respect to the remaining two-thirds which vested in monthly installments through the 3rd anniversary of the grant date.

F5 · balance_after: This employee's stock option was previously reported as covering 215,794 shares of common stock at an exercise price of $27.78 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.

SEC source: 0001209191-17-015845 · doc4.xml · nonDerivative · entry 3

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,555

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F3 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $41.88 to $42.53.

SEC source: 0001209191-17-015845 · doc4.xml · nonDerivative · entry 2

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,555

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

SEC source: 0001209191-17-015845 · doc4.xml · nonDerivative · entry 1

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,555

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $41.88 to $42.53.

SEC source: 0001209191-17-015246 · doc4.xml · nonDerivative · entry 1

BRADLEY KEITH · CIK 0001188650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,951

F1 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4.

SEC source: 0001209191-17-013193 · doc4.xml · nonDerivative · entry 1

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,518

SEC source: 0001209191-17-012193 · doc4.xml · nonDerivative · entry 3

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,573

F4 · shares: On February 15, 2017, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2016, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2017 at 150% target, the first anniversary of the grant date.

SEC source: 0001209191-17-012193 · doc4.xml · nonDerivative · entry 2

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,394

F3 · shares: On February 15, 2017, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2016, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 33% of the shares will vest on March 23, 2017, the second anniversary of the grant date.

SEC source: 0001209191-17-012193 · doc4.xml · nonDerivative · entry 1

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,824

F1 · shares: On February 15, 2017, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2016, at least a 3% increase in annual revenue over the prior fiscal year, under the March 24, 2014 Performance Stock Award. Accordingly, 34% of the shares will vest on March 24, 2017, the third anniversary of the grant date.

F2 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date and one additional unit of unvested performance based restricted stock ("PSU") for each PSU owned as of that date, as reflected in the totals listed on this Form 4.

SEC source: 0001209191-17-012104 · doc4.xml · nonDerivative · entry 3

Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,777

F4 · shares: On February 15, 2017, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2016, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2017 at 150% target, the first anniversary of the grant date.